NasdaqGM:SYM
NasdaqGM:SYMMachinery

Does Partnering With Nyobolt Signal a New Era for Symbotic’s (SYM) Warehouse Automation Strategy?

In recent days, Symbotic announced a collaboration with Nyobolt to enhance the performance and durability of its SymBot autonomous mobile robots, while ongoing demand for the company’s warehouse automation tools continues to be reinforced by artificial intelligence adoption and a strong US$22.4 billion backlog. Symbotic’s commercial agreements, particularly its partnership with Walmart, and advances in automation technology have positioned it to further streamline logistics operations across...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

Assessing MGE Energy (MGEE): Is the Utility’s Current Valuation Justified After Recent Share Price Resilience?

MGE Energy (MGEE) has caught some fresh attention following a recent shift in its stock price over the past month. There has been quiet resilience in this utility player, which makes it an interesting stock to revisit for long-term investors. See our latest analysis for MGE Energy. While MGE Energy’s share price has slipped around 9% year-to-date, this comes after a strong multi-year run, with the total shareholder return up nearly 39% over three years. The recent move hints at a pause in...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Recursion Pharmaceuticals (RXRX): Evaluating Valuation After AI Collaborations, Exscientia Deal, and Industry Leadership Moves

Recursion Pharmaceuticals (RXRX) caught Wall Street’s attention again this week as a wave of new AI-driven partnerships and technology upgrades put its platform in the spotlight. The company’s leadership presence at high-profile conferences is also adding to the buzz. See our latest analysis for Recursion Pharmaceuticals. Following several AI-driven collaborations and high-profile conference appearances, Recursion’s 30-day share price return has surged by 19.35%, even as its year-to-date...
NasdaqGM:ARTV
NasdaqGM:ARTVBiotechs

Artiva Biotherapeutics (ARTV): Evaluating Valuation After FDA Fast Track Milestone for Refractory Rheumatoid Arthritis Therapy

Artiva Biotherapeutics (ARTV) recently secured Fast Track Designation from the U.S. FDA for its AlloNK therapy in combination with rituximab, a treatment aimed at refractory rheumatoid arthritis. This recognition has captured significant market attention. See our latest analysis for Artiva Biotherapeutics. Artiva Biotherapeutics shares rocketed after news of the FDA Fast Track Designation, notching a remarkable 108.7% 1-month share price return and delivering 132.9% over the past 90 days...
NYSE:KSS
NYSE:KSSMultiline Retail

Sizing Up Kohl's After 33% Meme Rally and Analyst Price Target Hike

Trying to figure out what to do with Kohl's stock right now? You are not alone. Plenty of investors are tuning in after a rollercoaster few months, with headlines ranging from analysts bumping up their price targets to the stock becoming a center of “meme” stock buzz. Despite short-term swings, uncertainty, and even some skepticism about how the company is handling its bills, Kohl's shares have attracted lots of attention from retail investors hoping for a turnaround. Let us unpack the...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

A Look at Array Technologies (ARRY) Valuation After Analyst Upgrades and APA Solar Acquisition

Array Technologies (ARRY) has caught the market’s attention after a series of analyst upgrades and its recent acquisition of APA Solar. Industry watchers are now keen to see how these moves will impact the company’s next phase. See our latest analysis for Array Technologies. After a strong run on the back of analyst upgrades and the APA Solar deal, Array Technologies’ 1-month share price return stands at 8.4%, with a remarkable 24% gain over the last 90 days. Momentum is clearly building, and...
NYSE:BAC
NYSE:BACBanks

Bank of America (BAC): Valuation in Focus After Strong Q3 Earnings and Upbeat Guidance

Bank of America (BAC) just posted third-quarter results that outpaced expectations, driven by impressive consumer and investment banking strength. Net interest income climbed year over year, and management raised its guidance for the fourth quarter. See our latest analysis for Bank of America. Bank of America’s recent momentum is hard to ignore. After delivering a standout quarter and announcing new preferred dividends, the share price has climbed to $51.28, with a year-to-date share price...
NYSE:CMRE
NYSE:CMREShipping

A Look at Costamare (NYSE:CMRE) Valuation Following New High-Vote Share Issuance to Bolster Family Control

Costamare (NYSE:CMRE) has issued 1,200 Series F high-vote, non-economic preferred shares to the Konstantakopoulos family, increasing their voting power to 75.7%. This move helps the company align with new Chinese rules that restrict U.S. control in vessel operations. See our latest analysis for Costamare. Costamare’s latest move to shore up family control comes after a strong run for shareholders. The stock’s three-year total return is an impressive 84%, with a five-year total return topping...
NYSE:SNX
NYSE:SNXElectronic

How TD SYNNEX’s (SNX) New SIMO Partnership Could Shape Its Connectivity Market Strategy

In the past week, SIMO announced that TD SYNNEX would become its global distribution partner within the SIMO Alliance Program, expanding access to SIMO’s AI-powered multi-carrier connectivity solutions and vSIM technology for partners and customers worldwide. This collaboration enables TD SYNNEX to further broaden its product offerings in advanced connectivity and leverages its global logistics capabilities to deliver seamless cellular network solutions through its extensive distribution...
XTRA:CEC
XTRA:CECSpecialty Retail

Ceconomy’s (XTRA:CEC) Index Exit: Could Shifting Investor Demand Change Its Strategic Path?

Ceconomy AG was recently removed from the Germany Small DAX (Total Return) Index, changing its status among tracked German equities. This exclusion may affect its visibility and demand from funds that track the index, influencing the company’s relationship with institutional investors. We’ll explore how Ceconomy's index removal may impact its investment case, especially regarding its profile among index-oriented investors. We've found 18 US stocks that are forecast to pay a dividend yield of...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

AeroVironment (AVAV) Valuation in Focus After Strong Share Price Momentum and Recent Volatility

AeroVironment (AVAV) stock has attracted attention in recent weeks, largely driven by its recent price momentum and solid financial performance. Shares are up 26% over the past month, prompting investors to take a fresh look at the company's trajectory. See our latest analysis for AeroVironment. After surging more than 25% in the past month, AeroVironment's share price momentum is drawing interest as expectations remain high and yearly gains are strong. While a sharp 14% drop this past week...
ASX:SKS
ASX:SKSElectrical

Undiscovered Gems in Australia for October 2025

As the Australian market experiences a robust start to the week, buoyed by financial sector gains and anticipation surrounding the Albo-Trump meeting, investors are closely monitoring developments in rare earths amidst geopolitical tensions. In such dynamic conditions, identifying promising small-cap stocks requires a keen eye for companies poised to benefit from strategic partnerships and emerging industry trends.
ASX:BKI
ASX:BKICapital Markets

3 ASX Penny Stocks With Over A$100M Market Cap

The Australian market started the week strong, with the XJO climbing above 9,000 points, driven by gains in the financials sector as anticipation builds around a key meeting between Anthony Albanese and Donald Trump. In this context of economic shifts and strategic discussions on critical minerals, penny stocks remain an intriguing investment area for those seeking potential growth in smaller or newer companies. Despite their outdated name, these stocks can still offer surprising value when...
NYSE:SEI
NYSE:SEIEnergy Services

Will Amanda Brock’s Appointment as Co-CEO Shift Solaris Energy Infrastructure’s (SEI) Long-Term Growth Outlook?

Solaris Energy Infrastructure announced on October 16, 2025 that Amanda Brock has been appointed as Co-Chief Executive Officer and to its Board of Directors, following extensive executive roles at Aris Water Solutions and within the global energy sector. Brock’s appointment brings a deep background in water, power, and infrastructure leadership, placing emphasis on water recycling and technology-driven sustainability across energy operations. We'll explore how Amanda Brock's addition to the...
XTRA:SZU
XTRA:SZUFood

Südzucker (XTRA:SZU): Assessing Valuation After Swing to Loss in Latest Earnings Announcement

Südzucker (XTRA:SZU) just posted its latest half-year results, showing a clear shift in momentum as both sales and profits declined compared to last year and moved into the red for the period. See our latest analysis for Südzucker. The sharp decline in Südzucker’s recent earnings, swinging from profit to loss, appears to have weighed on investor sentiment. After a brief uptick, the share price has slipped this year, with a 1-year total shareholder return of -8.9%, reflecting fading market...
ENXTAM:CCEP
ENXTAM:CCEPBeverage

How Investors May Respond To Coca-Cola Europacific Partners (ENXTAM:CCEP) Ongoing Share Buybacks and Insider Purchases

In October 2025, Coca-Cola Europacific Partners continued its share buyback program, repurchasing and canceling over 106,000 ordinary shares as part of a broader initiative that could total €1 billion. Additionally, senior managers Ana Callol and Jose Antonio Echeverria acquired company shares through the Employee Share Purchase Plan, reinforcing alignment between leadership and shareholder interests. These actions highlight the company's commitment to enhancing shareholder value and reflect...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics (DGX): A Fresh Valuation Check as Quarterly Earnings Take the Spotlight

Quest Diagnostics (DGX) is preparing to announce its quarterly earnings this Tuesday before the market opens. As the first in its peer group to report this season, all eyes are on the company’s results and the market reaction. See our latest analysis for Quest Diagnostics. Quest Diagnostics has been steadily regaining momentum, with a 3.2% share price return for the month and an impressive 25.5% share price return so far in 2025. Over the past year, the total shareholder return reached 31.0%,...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

How Investors May Respond To Ocular Therapeutix (OCUL) Securing FDA SPA for AXPAXLI Phase 3 Trials

Earlier this month, Ocular Therapeutix announced that the US FDA granted a Special Protocol Assessment for its planned Phase 3 trials of AXPAXLI in non-proliferative diabetic retinopathy, formalizing agreement on key trial design elements necessary for regulatory submission. This regulatory milestone not only advances AXPAXLI toward late-stage development but also aligns with the company's goals to expand treatment options in high-need retinal disease indications. We'll explore how the FDA's...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Halozyme Therapeutics (HALO): Examining Valuation After Recent Share Price Gains

Halozyme Therapeutics (HALO) has caught the attention of investors after its stock showed a modest gain today. While there is no major news event driving the move, market watchers are keeping an eye on its recent performance trends and financials. See our latest analysis for Halozyme Therapeutics. Halozyme’s latest share price moves have come after a robust stretch. The stock has delivered a 39.6% year-to-date share price return and a 29.5% total return over the past year, signaling that...
OM:OEM B
OM:OEM BTrade Distributors

Can OEM International's (OM:OEM B) Resilient Earnings Sustain Its Competitive Edge?

OEM International AB (publ) recently reported its third quarter and nine-month 2025 earnings, with third quarter sales reaching SEK 1,280 million and net income of SEK 161 million, both higher than the same period last year. Despite a slight decrease in nine-month net income, the company showed steady operational performance through consistent sales growth and stable earnings per share figures. Let's explore how this steady operational performance and resilience reflected in the recent...
NYSE:SLG
NYSE:SLGOffice REITs

SL Green Realty (SLG): Evaluating Value After Profitable Q3 and Major Manhattan Acquisitions

SL Green Realty (SLG) just announced its third-quarter 2025 results, showing a swing back to net income with higher revenues compared to last year. The company also unveiled major lease signings and new property acquisitions in Manhattan. See our latest analysis for SL Green Realty. Even with upbeat quarterly results and some eye-catching Manhattan acquisitions, SL Green Realty's share price hasn’t escaped the recent drag in real estate stocks. The company has logged a 1-year total...
NYSE:PCG
NYSE:PCGElectric Utilities

Will Easing Wildfire Liability Concerns and Regulatory Support Change PG&E's (PCG) Narrative?

In recent days, analysts and market participants have expressed renewed confidence in PG&E, citing easing concerns over wildfire-related liabilities and highlighting ongoing efforts in wildfire mitigation and regulatory protections under California law. This shift in perception reflects recognition of PG&E's substantial investment in wildfire risk management and the potential impact of favorable legislative frameworks on the company’s financial stability. We’ll see how this improved...